“hepatitis-c” Archives

in
Entry Author Date Location
Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More 07/08/16 National
KaloBios Deals With Shkreli After Exiting Bankruptcy With New Cash 07/07/16 San Francisco
Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug 06/27/16 San Diego
Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More 06/10/16 National
East Coast Biotech Roundup: Harvard’s Haul, Patent Fights, Padlock & More 03/24/16 Boston
West Coast Bio Roundup: CRISPR Patent, HCV Data, Verily Digs & More 02/19/16 San Francisco
East Coast Biotech Roundup: Editas, Hep C, Akashi, Tarveda & More 01/29/16 Boston
Innovation vs. Healthcare Spending: Biotech’s Biggest Looming Challenge 12/28/15 National
West Coast Bio Roundup: Shkreli Cuffed, KaloBios Halted & More 12/17/15 National
Biogen Helps Put $42.5M Into a Father’s Duchenne Gene Therapy Quest 11/05/15 Boston
Pharma Plays The “Value” Card: Drug Spending Then And Now 09/14/15 National
FDA Approves Vertex’s Two-Drug Combo For Cystic Fibrosis 07/02/15 Boston
Vertex Teams up With Durham’s Parion in $80M Lung Drug Deal 06/04/15 Boston
East Coast Biotech Roundup: Bluebird, Sarepta, Synlogic & More 05/22/15 Boston
West Coast Biotech Roundup: Orexigen, Denali, Nant, ASCO & More 05/15/15 San Diego
FDA Panel Backs Vertex’s Two-Drug Combo For Cystic Fibrosis 05/12/15 Boston
The Innovation Challenge: Assessing BioPharma Startups 05/04/15 Seattle
Reflections on the “Build to Buy,” Part 2: The Applicability Problem 04/30/15 National
East Coast Biotech Roundup: Cellectis, Bristol, What’s Hot & More 04/13/15 Boston
Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia? 03/23/15 National
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More 03/16/15 Boston
AbbVie Snaps up Pharmacyclics, Pays Whopping $21B For Cancer Drug 03/05/15 National
East Coast Biotech Roundup: Vertex, Syndax, Build-to-Buy Deals & More 02/20/15 Boston
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
West Coast Biotech Roundup: Dendreon, Invitae, Juno, Regulus & More 02/12/15 Seattle
Gilead Exec: More Value in Quick Hep C Cure than Cancer Treatments 02/10/15 San Francisco
East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More 02/09/15 Boston
FDA’s Hamburg Stepping Down With Biopharma Turnaround as Her Legacy 02/05/15 National
East Coast Biotech Roundup: Alnylam, Stock Offerings, Curis, & More 01/23/15 Boston
J.P. Morgan 2015: Notes, Thoughts, And Conversations From the Vortex 01/16/15 National
Page 1 of 9 next page »